Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-29

Clinical Trial Update: A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating OPTI-BIOME Bacillus subtilis MB40 for abdominal discomfort, gas, and bloating in healthy individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPTI-BIOME (Bacillus subtilis MB40)

Snippet

Sponsor: BIO-CAT Microbials, LLC | Conditions: Bloating | Phase 2 | Status: COMPLETED